Willian Orlando Castillo Ordoñez

From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease

Talita P.C. Chierrito, Susimaire Pedersoli-Mantoani, Carlos Roca et al. · European Journal of Medicinal Chemistry · 2017 · 54 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell line

Willian Orlando Castillo Ordoñez, Andrés Felipe Aristizábal-Pachón, Ana Paula de Lima Montaldi et al. · NeuroToxicology · 2016 · 43 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Assessment of anti-cholinesterase activity and cytotoxicity of cagaita (Eugenia dysenterica) leaves

Cristian Aldemar Gasca Silva, Willian Orlando Castillo Ordoñez, Catarina Satie Takahashi et al. · Food and Chemical Toxicology · 2017 · 34 citations

Life Sciences, Botany, Pharmacology +5

Genotoxic evaluation of occupational exposure to antineoplastic drugs

Andrés Felipe Aristizábal-Pachón, Willian Orlando Castillo Ordoñez · Toxicological Research · 2019 · 24 citations · Full text

Pharmacy, Toxicology, Occupational Health +14

Genistein and Galantamine Combinations Decrease β-Amyloid Peptide (1–42)–Induced Genotoxicity and Cell Death in SH-SY5Y Cell Line: an In Vitro and In Silico Approach for Mimic of Alzheimer’s Disease

Willian Orlando Castillo Ordoñez, Nilza Velasco Palomino, Catarina Satie Takahashi et al. · Neurotoxicity Research · 2020 · 21 citations

Life Sciences, Neuroscience, Toxicology +17